A breakthrough app won the Henry Ford Health System’s first artificial intelligence challenge. A team from Israel developed the app to assist in monitoring conditions such as Parkinson’s and hydrocephalus.…
According to an article from Parkinson's News Today, a recent analysis testing transcranial magnetic stimulation demonstrated that the procedure was not effective in treating the depression that is a common…
A new clinical study starts soon and researchers are looking for 75 volunteers. The phase two clinical trial will be testing the safety and tolerability of the drug nilotinib in…
Doctors of semi-professional soccer player, Matt Dimbylow, believes he developed Parkinson's disease at the young age of 36-years-old due to a head injury he sustained playing the sport, reports Mirror.…
Coffee or tea is the preferred way for many people to start their morning. That extra boost of caffeine just seems to get things rolling. New research suggests that caffeine…
Doctors from the Colorado University School of Medicine recently conducted research indicating that an exercise protein could help prevent the onset of Parkinson’s disease symptoms. Parkinson’s disease is a rare…
The Washington Post published a bizarre story earlier this month that is equal parts interesting and terrifying! A US National Security Agency counterintelligence officer (AKA a spy) is claiming that while…
Although Parkinson's disease (PD) affects men and women equally, researchers have discovered an area of disparity: care giving. A study published this month in Neurology by researchers at the Perelman School of Medicine…
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
